This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
HIV Infections
and you are
between 18 and 65
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to determine efficacy of the combination of low dose of Tenofovir, Efavirenz and Lamivudine in treating HIV-infection.

Provided treatments

  • Drug: Tenofovir(TDF)+Lamivudine(3TC)+Efavirenz(EFV)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02632474. The sponsor of the trial is Shanghai Public Health Clinical Center and it is looking for 10 volunteers for the current phase.
Official trial title:
ART Drug Dosage Adjustment Using FSCII in Chinese HIV-infected Population